Skip to main content

Advertisement

Log in

Granulomatous Diseases of the Central Nervous System

  • Neurology of Systemic Diseases (J. Biller, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To discuss the pathophysiology, key clinical features, necessary diagnostic evaluation, and current treatment regimens for granulomatous diseases of the central nervous system.

Recent findings

The diagnosis and management of granulomatous disease of the central nervous system has been revolutionized by advances in diagnostic imaging. Nevertheless, tissue and/or cerebrospinal fluid (CSF) sampling remains necessary to establish the diagnosis in most cases. Establishing a specific diagnosis is critical because treatment selection needs to focus on the granulomatous process centering on either antibiotic or immunosuppressive agents. Particular for non-infectious granulomatous disease more aggressive immunotherapies may help in clinical outcome.

Summary

There are multiple non-infectious and infectious etiologies for granulomatous disease of the central nervous system. Clinical manifestations result from local structural invasion of granulomas or granulomatous inflammation of the blood vessels and meninges. Rapid diagnosis and specific treatment is essential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Da Rocha AJ, Martins Maia AC, Fortes Ferreira NPD, Faria Do Amaral, L. L. Granulomatous diseases of the central nervous system. Top Magn Reson Imaging. 2005;16(2):155–87. https://doi.org/10.1097/01.rmr.0000189109.62899.a1.

    Article  PubMed  Google Scholar 

  2. •Rapalino O, Mullins ME. Intracranial Infectious and Inflammatory Diseases Presenting as Neurosurgical Pathologies. Neurosurgery. 2017;81(1):10–28. https://doi.org/10.1093/neuros/nyx201 (Summary of common neurosurgical interventions for various neuroinfectious diseases.).

    Article  PubMed  Google Scholar 

  3. Nowak DA, Widenka DC. Neurosarcoidosis: A review of its intracranial manifestation. J Neurol. 2001;248(5):363–72. https://doi.org/10.1007/s004150170175.

    Article  CAS  PubMed  Google Scholar 

  4. Lury KM, Smith JK, Matheus MG, Castillo M. Neurosarcoidosis - Review of imaging findings. Semin Roentgenol. 2004;39(4):495–504. https://doi.org/10.1016/j.ro.2004.06.006.

    Article  PubMed  Google Scholar 

  5. Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a Unique Time-Space Cluster of Sarcoidosis in Firefighters. Am Rev Respir Dis. 1993;148(4_pt_1):974–80. https://doi.org/10.1164/ajrccm/148.4_Pt_1.974.

    Article  CAS  PubMed  Google Scholar 

  6. Hills SE, Parkes SA, de Baker SBC. Epidemiology of sarcoidosis in the Isle of Man - 2: Evidence for space-time clustering. Thorax. 1987;42(6):427–30. https://doi.org/10.1136/thx.42.6.427.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224–34. https://doi.org/10.1056/NEJM199704243361706.

    Article  CAS  Google Scholar 

  8. Kidd DP. Neurosarcoidosis: Clinical manifestations, investigation and treatment. Pract Neurol. 2020;20(3):199–212. https://doi.org/10.1136/practneurol-2019-002349.

    Article  PubMed  Google Scholar 

  9. Bergantini L, et al. Prognostic biomarkers pf sarcoidosis: A comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6. Hindawi. 2019. https://doi.org/10.1155/2019/8565423.

    Article  Google Scholar 

  10. Stern BJ, Aksamit A, Clifford D, Scott TF. Neurologic Presentations of Sarcoidosis. Neurol Clin. 2010;28(1):185–98. https://doi.org/10.1016/j.ncl.2009.09.012.

    Article  PubMed  Google Scholar 

  11. ••Kidd DP. “Sarcoidosis of the central nervous system: clinical features, imaging, and CSF results.” J Neurol. 2018;265(8):1906–15. https://doi.org/10.1007/s00415-018-8928-2 (Discussion of the multiple and protean characteristics and presentation of Neurosarcodosis.).

    Article  PubMed  Google Scholar 

  12. S. Bitoun et al. “Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.” Neurology 2016; 2517–2522.

  13. Baughman RP, Lower EE. Treatment of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):79–92. https://doi.org/10.1007/s12016-015-8492-9.

    Article  CAS  PubMed  Google Scholar 

  14. •Gelfand JM, et al. Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series. Neurology. 2017;89(20):2092–100. https://doi.org/10.1212/WNL.0000000000004644 (Review of infliximab therapy for the treatment of CNS sarcoidosis.).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. •Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in wegener granulomatosis. Medicine (Baltimore). 2006;85(1):54–65. https://doi.org/10.1097/01.md.0000200166.90373.41 (Analysis of granulomatous polyangiitis and its impact on the CNS.).

    Article  Google Scholar 

  16. Joshi S, et al. Rheumatoid arthritis with pachymeningitis – a case presentation and review of literature. Reumatologia. 2020;58:116–22. https://doi.org/10.5114/reum.2020.95368.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Schwenkenbecher P, et al. Chronic granulomatous disease first diagnosed in adulthood presenting with spinal cord infection. Front Immunol. 2018;9(JUN):1–6. https://doi.org/10.3389/fimmu.2018.01258.

    Article  Google Scholar 

  18. ••Arshad A, et al. Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment. J Clin Med. 2020;9(9):2962. https://doi.org/10.3390/jcm9092962 (Highlights the new data regarding treatment of CNS tuberculosis (see also reference 27).).

    Article  PubMed Central  Google Scholar 

  19. Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One. 2011;6(5):2011. https://doi.org/10.1371/journal.pone.0020077.

    Article  CAS  Google Scholar 

  20. Patkar D, Narang J, Yanamandala R, Lawande M, Shah GV. Central Nervous System Tuberculosis. Neuroimaging Clin North Am. 2012;22(4):677–705. https://doi.org/10.1016/j.nic.2012.05.006.

    Article  Google Scholar 

  21. Schaller MA, Wicke F, Foerch C, Weidauer S. Central Nervous System Tuberculosis: Etiology, Clinical Manifestations and Neuroradiological Features. Clin Neuroradiol. 2019;29(1):3–18. https://doi.org/10.1007/s00062-018-0726-9.

    Article  PubMed  Google Scholar 

  22. ••Da Rocha AJ, et al. Granulomatous diseases of the central nervous system. Neurosurgery. 2011;16(1):10–28. https://doi.org/10.1093/neuros/nyx201 (Comprehensive review on the importance of tissue sampling for GNLD of the CNS.).

    Article  Google Scholar 

  23. Leonard JM. Central Nervous System Tuberculosis. Microbiol Spectr. 2017;5(2):2017. https://doi.org/10.1128/microbiolspec.TNMI7-0044-2017.

    Article  Google Scholar 

  24. Zahrou F, Elallouchi Y, Ghannane H, Benali SA, Aniba K. Diagnosis and management of intracranial tuberculomas: About 2 cases and a review of the literature. Pan Afr Med J. 2019;34:23. https://doi.org/10.11604/pamj.2019.34.23.17587.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bernaerts A, et al. Tuberculosis of the central nervous system: Overview of neuroradiological findings. Eur Radiol. 2003;13(8):1876–90. https://doi.org/10.1007/s00330-002-1608-7.

    Article  CAS  PubMed  Google Scholar 

  26. Kumar K. Spinal tuberculosis, natural history of disease, classifications and principles of management with historical perspective. Eur J Orthop Surg Traumatol. 2016;26(6):551–8. https://doi.org/10.1007/s00590-016-1811-x.

    Article  PubMed  Google Scholar 

  27. Marais S, et al. Management of intracranial tuberculous mass lesions: how long should we treat for? Wellcome Open Res. 2019;4:158. https://doi.org/10.12688/wellcomeopenres.15501.2.

    Article  PubMed  Google Scholar 

  28. •J. A. Seddon et al. (2020) “The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes [version 1 ; peer review : 2 approved ].” Wellcome Open Res., pp. 1–15. Epidemiologic review of tuberculous meningitis.

  29. Anagnostou T, Arvanitis M, Kourkoumpetis TK, Desalermos A, Carneiro HA, Mylonakis E. Nocardiosis of the central nervous system: Experience from a general hospital and review of 84 cases from the literature. Med (United States). 2014;93(1):19–32. https://doi.org/10.1097/MD.0000000000000012.

    Article  Google Scholar 

  30. Ambrosioni J, Lew D, Garbino J. Nocardiosis: Updated clinical review and experience at a tertiary center. Infection. 2010;38(2):89–97. https://doi.org/10.1007/s15010-009-9193-9.

    Article  CAS  PubMed  Google Scholar 

  31. Shao X, Qiang D, Liu Y, Yuan Q, Tao J, Ji B. Diagnosis and Treatment of Cerebral Syphilitic Gumma: A Report of Three Cases. Front Neurosci. 2018;12(February):1–6. https://doi.org/10.3389/fnins.2018.00100.

    Article  Google Scholar 

  32. Li C, Wang S, Tang G, Liu L, Chen G. Neuroimaging findings of cerebral syphilitic gumma. Exp Ther Med. 2019;18(6):4185–92.https://doi.org/10.3892/etm.2019.8089.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system - Prognosis, diagnostics and treatment. J Infect. 2015;71(3):281–93. https://doi.org/10.1016/j.jinf.2015.06.004.

    Article  PubMed  Google Scholar 

  34. Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection. 2016;44(3):337–45. https://doi.org/10.1007/s15010-015-0867-6 (Specific discussion of the most common causes of viral GNLD of the CNS.).

    Article  CAS  PubMed  Google Scholar 

  35. Nagel MA, Niemeyer CS, Bubak AN. Central nervous system infections produced by varicella zoster virus. Current Opinion in Infectious Diseases. 2020;33(3):273–8. https://doi.org/10.1097/QCO.0000000000000647.

    Article  PubMed  Google Scholar 

  36. Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol. 2001;11(4):440–51. https://doi.org/10.1111/j.1750-3639.2001.tb00413.x.

    Article  CAS  PubMed  Google Scholar 

  37. G. Bhat, D. S. Mathur, G. N. Saxena, S. Jain, A. P. Singh, and D. Bhaduria, “Granulomatous angiitis of the central nervous system associated with herpes zoster.” J. Assoc. Physicians India, vol. 50, no. 7, pp. 977–978, 2002. Accessed: May 30, 2021. [Online]. Available: https://europepmc.org/article/med/12126361.

  38. •Y. Xiang et al. “Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review.” Front. Neurol., 2020;11. doi: https://doi.org/10.3389/fneur.2020.00901. Focused discussion regarding primary CNS lymphomatoid granulomatosis.

  39. Melani C, Jaffe ES, Wilson WH. Blood. 2020;135(16):1344–52. https://doi.org/10.1182/BLOOD.2019000933.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Bush JW, Wuerz T, Embil JM, Del Bigio MR, McDonald PJ, Krawitz S. Outcomes of persons with blastomycosis involving the central nervous system. Diagn Microbiol Infect Dis. 2013;76(2):175–81. https://doi.org/10.1016/j.diagmicrobio.2013.03.002.

    Article  PubMed  Google Scholar 

  41. Parija S, Venugopal H, Kp D. Management of granulomatous amebic encephalitis: Laboratory diagnosis and treatment. Trop Parasitol. 2015;5(1):23. https://doi.org/10.4103/2229-5070.149889.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Betting LE, Pirani C, De Queiroz LS, Damasceno BP, Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol. 2005;62(6):1008–10. https://doi.org/10.1001/archneur.62.6.1008.

    Article  PubMed  Google Scholar 

  43. Carpio A, Romo ML, Parkhouse RME, Short B, Dua T. Parasitic diseases of the central nervous system: Lessons for clinicians and policy makers. Expert Rev Neurother. 2016;16(4):401–14. https://doi.org/10.1586/14737175.2016.1155454 (Overview of several parasitic diseases that impact the CNS.).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Procop GW. North American paragonimiasis (caused by Paragonimus kellicotti) in the context of global paragonimiasis. Clin Microbiol Rev. 2009;22(3):415–46. https://doi.org/10.1128/CMR.00005-08.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael J. Schneck.

Ethics declarations

Conflict of Interest

Braden Dasovic, Ewa Borys, and Michael J. Schneck each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Neurology of Systemic Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dasovic, B., Ewa Borys & Schneck, M.J. Granulomatous Diseases of the Central Nervous System. Curr Neurol Neurosci Rep 22, 33–45 (2022). https://doi.org/10.1007/s11910-022-01173-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-022-01173-y

Keywords

Navigation